Drug News
-
Fundamental Changes To Medicare’s Part D Drug Benefits for 2024
Image Source Medicare open enrollment is here. It’s time again to review your options and make any necessary changes to…
Read More » -
West Pharmaceutical Services Boosts 2023 Profit Forecast Amidst Shifting Market Dynamics
West Pharmaceutical Services (WST.N), a leading medical equipment maker, announced on Thursday that it has revised its 2023 adjusted profit…
Read More » -
Demand for RSV Protection Shot for Babies Outpaces Supply, Prompts CDC Recommendation
In response to soaring demand, the supply of nirsevimab (Beyfortus), a novel vaccine designed to safeguard babies against respiratory syncytial…
Read More » -
International Flavors & Fragrances (IFF) Explores Potential $3.5 Billion Sale of Pharma Solutions Business
International Flavors & Fragrances (IFF.N) has initiated discussions with an advisor to consider the possibility of selling its pharma solutions…
Read More » -
Royalty Pharma Expands Ownership of Evrysdi Royalties with $1 Billion Investment in Roche SMA Drug
Royalty Pharma (RPRX.O) has announced the acquisition of additional royalties for Roche (ROG.S) and PTC Therapeutics’ (PTCT.O) oral spinal muscular…
Read More » -
UNION Therapeutics to Present at 7th Annual Dermatology Drug Development Summit in Boston
HELLERUP, Denmark, Oct. 25, 2023. UNION Therapeutics A/S (UNION), a leading clinical-stage pharmaceutical development company specializing in immunology and infectious…
Read More » -
Upcoming Event: 1st Academic Conference of Safety Psychology and Behavior for Healthcare
The International Association of Risk Management in Medicine (IARMM) has announced the Joint Conference for Clinical Safety Promotion, featuring the…
Read More » -
Hamilton Field Services Forge Expert Partnerships in Pharma and Life Sciences Industries
RENO, Nev., Oct. 24, 2023 – Hamilton, the globally recognized leader in automation technology and analytical sensors, has unveiled a…
Read More » -
Study Reveals 72% of Consumers Concerned About Health Data Misuse, as Lack of Informed Consent Tops Data Privacy Worries
WARRINGTON, England, Oct. 24, 2023. A recent research report released by Cassie, a globally recognized consent management platform serving Fortune…
Read More » -
Innovative Anti-Tumor Drug, LX-039, Shows Promise in Phase I Clinical Study Data Presented at ESMO 2023
SHANGHAI, Oct. 23, 2023 — Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical) has made a significant stride in the…
Read More »